Private company

Performant Healthcare Inc

American miscellaneous business services company, incorporated in Delaware1

In its 2025 annual report the company says: “We are a leading provider of these services in both government and commercial healthcare markets. We also provide advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. We endeavor to automate and optimize what traditionally have been manually intensive processes in order to drive higher workforce productivity.”4 It is headquartered in Plantation, Florida.1

Last updated Oct 20, 2026.

Overview

  • IndustryServices-Miscellaneous Business Services1
  • HeadquartersPlantation, Florida1
  • Incorporated inDE2
  • Business address900 South Pine Island Road, Suite 150, Plantation, Fl 333242
  • Filer categoryAccelerated filer, Smaller reporting company2

We support payers in the healthcare industry with identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and proprietary data assets. We work with leading national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB), services as well as claims-based services. Our eligibility based services involve identifying and recovering payments in situations where our client should not be the primary payer of healthcare claims because a member has other forms of insurance coverage, while our claims-based services include the audit and identification of improperly paid claims. We are a leading provider of these services in both government and commercial healthcare markets. We also provide advanced reporting capabilities, support services, customer care, and stakeholder training programs des…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-7.7%Operating margin5
-8.0%Net margin5
8.1%Revenue growth, 20245
-12.9%Return on equity5
-$832.0KFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Other costs100¢$122.6M
  • Income tax0¢$351.0K

Out of $123.0M in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Capital spending100¢$7.0M

Out of $6.2M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5

Financial statements

Revenue6789105$123.0M in 2024−21% since 2018
0$50.0M$100.0M$150.0M$200.0M2018: $155.7M$155.7M20182019: $150.4M$150.4M2019−3%2020: $155.9M$155.9M2020+4%2021: $124.4M$124.4M2021−20%2022: $109.2M$109.2M2022−12%2023: $113.7M$113.7M2023+4%2024: $123.0M$123.0M2024+8%
Operating income6789105-$9.5M in 2024+429% since 2018
-$20.0M-$15.0M-$10.0M-$5.0M02018: -$1.8M-$1.8M20182019: -$19.6M-$19.6M2019+993%2020: -$14.0M-$14.0M2020−29%2021: -$1.3M-$1.3M2021−91%2022: -$6.9M-$6.9M2022+424%2023: -$6.1M-$6.1M2023−11%2024: -$9.5M-$9.5M2024+55%
Net income6789105-$9.9M in 2024+24% since 2018
-$30.0M-$20.0M-$10.0M02018: -$8.0M-$8.0M20182019: -$26.8M-$26.8M2019+235%2020: -$14.0M-$14.0M2020−48%2021: -$10.3M-$10.3M2021−26%2022: -$6.5M-$6.5M2022−36%2023: -$7.5M-$7.5M2023+15%2024: -$9.9M-$9.9M2024+32%
Fiscal year2018201920202021202220232024
Revenue$155.7M6$150.4M7$155.9M8$124.4M9$109.2M10$113.7M5$123.0M5
Operating expenses$125.7M9$116.1M10$119.9M5$132.5M5
Operating income-$1.8M6-$19.6M7-$14.0M8-$1.3M9-$6.9M10-$6.1M5-$9.5M5
Interest$4.7M6$7.6M7$7.2M8$11.3M9$1.0M10$2.0M10
Income before tax-$10.2M9-$6.4M10-$7.9M5-$10.2M5
Income tax$1.5M6-$377.0K7-$7.2M8$62.0K9$132.0K10-$340.0K5-$351.0K5
Net income-$8.0M6-$26.8M7-$14.0M8-$10.3M9-$6.5M10-$7.5M5-$9.9M5
Earnings per share-$0.156-$0.507-$0.268-$0.179-$0.0910-$0.105-$0.135
Earnings per share (diluted)-$0.156-$0.507-$0.268-$0.179-$0.0910-$0.105-$0.135
Shares (weighted, basic)60.5M shares972.9M shares1076.2M shares577.5M shares5
Shares (weighted, diluted)60.5M shares972.9M shares1076.2M shares577.5M shares5

Compare Performant Healthcare Inc with another company

Corporate structure

Performant Healthcare Inc sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Performant Healthcare Inc

  • Topline Capital Management, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Nov 14, 2025 (3 filings since Apr 18, 2024)
  • GLAZER CAPITAL, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Nov 13, 2025 (2 filings since Aug 21, 2025)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Oct 30, 2025 (2 filings since Jul 29, 2025)
  • PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Filed SCHEDULE 13D/A on Performant Healthcare Inc, latest Oct 23, 2025 (5 filings since Oct 7, 2021)
  • First Light Asset Management, LLC Filed SCHEDULE 13G/A on Performant Healthcare Inc, latest Aug 14, 2025 (5 filings since Feb 14, 2022)
  • PARTHENON INVESTORS II. L.P. Filed SC 13G/A on Performant Healthcare Inc, latest Feb 8, 2024 (3 filings since Feb 8, 2022)
  • ECMC Group, Inc. Filed SC 13G/A on Performant Healthcare Inc, latest Feb 14, 2023 (2 filings since Feb 7, 2022)
  • Mill Road Capital II, L.P. Filed SC 13D/A on Performant Healthcare Inc, latest Aug 31, 2022
  • Performant Healthcare Inc Plantation, Florida
    • Performant Business Services, Inc. Subsidiary · Nevada, United States
    • Performant Recovery, Inc. Subsidiary · California, United States
    • Performant Technologies, LLC. Subsidiary · California, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Performant Healthcare Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$61.9M5 Dec 31, 2024$74.3M5 Dec 31, 2023−16.7%
Accumulated depreciation$47.9M5 Dec 31, 2024$64.6M5 Dec 31, 2023−25.9%
Property and equipment, net$14.0M5 Dec 31, 2024$9.7M5 Dec 31, 2023+44.2%
Operating-lease assets (leased space)$826.0K5 Dec 31, 2024$531.0K5 Dec 31, 2023+55.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$9.3M5 Dec 31, 2024$7.3M5 Dec 31, 2023+28.1%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$47.4M5 Dec 31, 2024$47.4M5 Dec 31, 20230%

Properties, in its own words

Facilities

As of December 31, 2024, we operated four separate office locations throughout the United States. Our Plantation, Florida facility serves as our corporate headquarters.

The rest of Item 2

We believe that our facilities are adequate for current operations and that additional space will be available as required. See Note 4 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information regarding our lease obligations.

Item 2 of the 10-K filed Mar 13, 2025.4

Leadership

Who has led Performant Healthcare Inc, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (20)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Performant Business Services, Inc. Nevada3
  • Performant Recovery, Inc. California3
  • Performant Technologies, LLC. California3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Performant Financial CorpJun 18, 2012 to Nov 15, 20242

Timeline

  1. Oct 21, 20258-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer39
  2. Oct 17, 20258-K Shareholder vote40
  3. Aug 1, 20258-K Entered a material agreement; Executive or director change41
  4. Aug 1, 20258-K Results of operations42
  5. Jun 23, 20258-K Shareholder vote43
  6. May 8, 20258-K Results of operations44
  7. Mar 12, 20258-K Results of operations45
  8. Dec 10, 20248-K Bylaws or fiscal year changed46
  9. Nov 6, 20248-K Results of operations47
  10. Aug 7, 20248-K Results of operations48
  11. Jun 24, 20248-K Shareholder vote49
  12. May 7, 20248-K Results of operations50
  13. May 9, 2023New chief executive Simeon Kohl becomes CEO14
  14. Aug 9, 2012New chief executive Lisa Im becomes CEO15

Calendar

When it reported results

  1. Aug 1, 2025Reported quarterly or annual results42
  2. May 8, 2025Reported quarterly or annual results44
  3. Mar 12, 2025Reported quarterly or annual results45
  4. Nov 6, 2024Reported quarterly or annual results47
  5. Aug 7, 2024Reported quarterly or annual results48
  6. May 7, 2024Reported quarterly or annual results50
  7. Mar 12, 2024Reported quarterly or annual results51
  8. Nov 7, 2023Reported quarterly or annual results52

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

180 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 30 major events, 82 insider forms, 23 large holders, 29 other. The latest 20:

  1. Nov 20, 2025EFFECT EDGAR
  2. Nov 14, 2025SCHEDULE 13G/A EDGAR
  3. Nov 13, 2025SCHEDULE 13G/A EDGAR
  4. Oct 31, 202515-12G EDGAR
  5. Oct 30, 2025SCHEDULE 13G/A EDGAR
  6. Oct 23, 2025SCHEDULE 13D/A EDGAR
  7. Oct 22, 20254 EDGAR
  8. Oct 21, 20254 EDGAR
  9. Oct 21, 20254 EDGAR
  10. Oct 21, 20254 EDGAR
  11. Oct 21, 20254 EDGAR
  12. Oct 21, 20254 EDGAR
  13. Oct 21, 20254 EDGAR
  14. Oct 21, 20254 EDGAR
  15. Oct 21, 2025POS AM EDGAR
  16. Oct 21, 2025S-8 POS EDGAR
  17. Oct 21, 2025S-8 POS EDGAR
  18. Oct 21, 2025S-8 POS EDGAR
  19. Oct 21, 2025S-8 POS EDGAR
  20. Oct 21, 20258-K EDGAR

The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

30 open-market trades by officers, directors and large owners since October 2021: 18 buys and 12 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 3, 2025Im LisaDirectorSale180,867$3.25$587.8KForm 4
Dec 10, 2024Im LisaDirectorSale6,154$3.26$20.1KForm 4
May 10, 2023PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy30,000$2.61$78.3KForm 4
Mar 17, 2023PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% ownerBuy300,182$2.66$798.5KForm 4
Mar 16, 2023PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% ownerBuy2,770$2.80$7.8KForm 4
Mar 15, 2023PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% ownerBuy5,635$2.85$16.1KForm 4
Mar 25, 2022PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy100,000$2.84$284.0KForm 4
Mar 16, 2022ECMC Group, Inc.10% ownerSale194,334$2.27$441.1KForm 4
Mar 7, 2022ECMC Group, Inc.10% ownerSale24,229$2.00$48.5KForm 4
Mar 4, 2022ECMC Group, Inc.10% ownerSale17,219$2.01$34.6KForm 4
Mar 3, 2022ECMC Group, Inc.10% ownerSale22,434$2.06$46.2KForm 4
Mar 2, 2022ECMC Group, Inc.10% ownerSale52,650$2.19$115.3KForm 4
Mar 1, 2022ECMC Group, Inc.10% ownerSale27,425$2.12$58.1KForm 4
Feb 28, 2022ECMC Group, Inc.10% ownerSale26,662$2.32$61.9KForm 4
Feb 25, 2022ECMC Group, Inc.10% ownerSale16,500$2.25$37.1KForm 4
Feb 24, 2022ECMC Group, Inc.10% ownerSale39,072$2.19$85.6KForm 4
Feb 23, 2022ECMC Group, Inc.10% ownerSale20,000$2.32$46.4KForm 4
Jan 28, 2022PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy168,210$1.89$317.9KForm 4
Jan 27, 2022PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy115,025$1.91$219.7KForm 4
Jan 24, 2022PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP10% ownerBuy444,685$1.96$871.6KForm 4

All 30 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Performant Healthcare Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPerformant Healthcare Inc1
  • CIK0001550695
  • Employer ID (EIN)20-04849344
  • Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
  • Incorporated inDelaware4
  • Fiscal year endsDecember 311
  • Industry code (SIC)7380 Services-Miscellaneous Business Services1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address900 South Pine Island Road, Suite 150, Plantation, FL 333241
  • Mailing address4309 Hacienda Dr, Suite 110, Pleasanton, CA 945881
  • Phone925-960-48001
  • Shares outstanding78,997,024 as of Aug 6, 202512
  • Public float$127.8M as of Jun 30, 20244
  • AuditorBaker Tilly US, LLP, Atlanta, Georgia PCAOB ID 23; it also attests to the company’s internal control over financial reporting4
  • On EDGAR sinceJun 18, 20121
  • Filings696 in all: 4 (321), 8-K (114), 10-Q (39), SC 13G/A (36), 3 (25), CORRESP (14), DEFA14A (14), UPLOAD (14)1
    All 39 form types

    10-K (13), DEF 14A (13), SC 13G (13), SC 13D/A (10), EFFECT (9), S-1/A (8), S-3 (5), 424B5 (4), S-8 (4), S-8 POS (4), SC 13D (4), SCHEDULE 13G/A (4), 424B4 (3), S-1 (3), 10-K/A (2), 144 (2), PRE 14A (2), SCHEDULE 13D/A (2), SCHEDULE 13G (2), 15-12G (1), 25-NSE/A (1), 4/A (1), 8-A12B (1), 8-K/A (1), CERTNAS (1), DEFM14A (1), DEFR14A (1), NT 10-K (1), POS AM (1), PREM14A (1), S-1MEF (1)

  • Latest filingsAnnual report (10-K) Mar 13, 2025
    Quarterly report (10-Q) Aug 7, 2025
    Proxy statement (DEF 14A) Aug 5, 2025
    Latest 8-K (8-K) Oct 21, 2025

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $.0001 per sharePHLTNasdaq

From the cover page of the 10-K filed Mar 13, 2025 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Performant Healthcare Inc names in Item 1A of its 10-K filed Mar 13, 2025: 29 risks under these headings, as written.4

  • Risks Related to Our Business
  • We typically face a long period to start up a new contract which may cause us to incur expenses before we receive revenues from new clients or new contract relationships.
  • Revenues generated from a limited number of our largest clients represent a substantial majority of our revenues. Any termination of or deterioration in our relationship with any of our significant clients would result in a decline in our revenues.
  • Many of our contracts with our clients are not exclusive and do not commit our clients to provide specified volumes of business. In addition, the terms of these contracts may be changed unilaterally and on short notice by our clients. As a consequence, there is no assurance that we will be able to maintain our revenues and operating results.
  • We face significant competition in connection with obtaining, retaining and performing under our client contracts, and an inability to compete effectively in the future could harm our relationships with our clients, which would impact our ability to maintain our revenues and operating results.
  • Our ability to derive revenues under our current healthcare contracts will depend in part on the number and types of potentially improper claims that we are allowed to audit or otherwise pursue by our clients, and our results of operations may be harmed if the scope of claims that we are allowed to pursue and be compensated for is limited.
  • Our indebtedness could adversely affect our business and financial condition and reduce the funds available to us for other purposes, and our failure to comply with the covenants contained in our Credit Agreement could result in an event of default that could adversely affect our results of operations.
  • The U.S. federal government accounts for a significant portion of our revenues, and any loss of business from, or change in our relationship with the U.S. federal government would result in a significant decrease in our revenues and operating results.
  • We may not be able to manage our potential growth effectively and our results of operations could be negatively affected.
  • The growth of our healthcare business will require us to hire and retain employees with specialized skills and failure to do so could harm our ability to grow our business.
  • Downturns in domestic or global economic conditions and other macroeconomic factors could harm our business and results of operations.
  • We may not have sufficient cash flows from operations or availability of funds under our lending arrangements to fund our ongoing operations and our other liquidity needs, which could adversely affect our business and financial condition.
The other 18 risks
  • Public health emergencies such as the novel coronavirus (COVID-19) pandemic have adversely affected and could adversely affect our business, results of operations and financial condition.
  • Our results of operations may fluctuate on a quarterly or annual basis and cause volatility in the price of our stock.
  • Risks Related to Information Technology, Privacy Matters, and Intellectual Property
  • A failure of our operating systems or technology infrastructure, or those of our third-party vendors, service providers or subcontractors, could disrupt the operation of our business.
  • If our security measures are breached or fail and unauthorized access is obtained to our clients’ confidential data, our services may be perceived as insecure, the attractiveness of our services to current or potential clients may be reduced, and we may incur significant liabilities.
  • If our software vendors or utility and network providers fail to deliver or perform as expected our business operations could be adversely affected.
  • Increasing use of social media and new technology, including artificial intelligence software, could give rise to liability, breaches of data security, or reputational damage.
  • If we are unable to adequately protect our proprietary technology, our competitive position could be harmed, or we could be required to incur significant costs to enforce our rights.
  • Claims by others that we infringe their intellectual property could force us to incur significant costs or revise the way we conduct our business.
  • Risks Related to Regulations and Legislation
  • We identified a material weakness in our internal control over financial reporting in the fourth quarter of 2022. If we experience additional material weaknesses or other deficiencies, or if we are unable to remediate material weaknesses or other deficiencies identified in the future, or otherwise fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately or timely report our financial results, which could result in loss of investor confidence and adversely impact our stock price.
  • Future legislative or regulatory changes affecting the markets in which we operate could impair our business and operations.
  • We are subject to extensive regulations regarding the use and disclosure of confidential personal information and failure to comply with these regulations could cause us to incur liabilities and expenses.
  • Our legacy student loan recovery business is subject to extensive regulation and consumer protection laws and our failure to comply with these regulations and laws may subject us to liability and result in significant costs.
  • Risks Related to our Common Stock
  • The price of our common stock could be volatile, and you may not be able to sell your shares at or above the public offering price.
  • Our significant stockholders have the ability to influence significant corporate activities and our significant stockholders' interests may not coincide with yours.
  • General Risks
  • We may undertake strategic transactions or other corporate restructuring that prove unsuccessful, strain or divert our resources and harm our results of operations and stock price.
  • Litigation may result in substantial costs of defense, damages or settlement, any of which could subject us to significant costs and expenses.
  • Our business may be harmed if we lose members of our management team or other key employees.
  • Anti-takeover provisions contained in our certificate of incorporation and bylaws could impair a takeover attempt that our stockholders may find beneficial.

Legal proceedings

We are involved in various legal proceedings that arise from our normal business operations from time to time. The outcome of any such legal proceedings, regardless of the merits, is inherently unpredictable. Legal proceedings, including litigation, government investigations and enforcement actions, can result in significant costs and occupy significant management resources. We do not expect any such current legal proceedings to have a material adverse impact on our business or financial condition.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60